Maria C.  Freire net worth and biography

Maria Freire Biography and Net Worth

Dr. Maria C. Freire, Ph.D., is an Independent Director of Alexandria Real Estate Equities, Inc. She has served as a director since April 2012. In November 2012, Dr. Freire became the President and Executive Director, and a member of the board of directors, of the FNIH, a Congressionally authorized independent organization that draws together the world’s foremost researchers and resources in support of the mission of the National Institutes of Health (“NIH”). Prior to her appointment to the FNIH, Dr. Freire was the President and a member of the board of directors of the Albert and Mary Lasker Foundation, a non-profit organization that bestows the Lasker Awards in basic and clinical science and advocates for medical research. From 2001 to 2008, Dr. Freire served as President and Chief Executive Officer of the Global Alliance for TB Drug Development, a public-private partnership that develops better, faster-acting, and affordable drugs to fight tuberculosis. An expert in technology commercialization, she directed the Office of Technology Transfer at the NIH from 1995 to 2001 and served as a commissioner on the World Health Organization’s Commission on Intellectual Property Rights, Innovation and Public Health. Dr. Freire obtained her Bachelor of Science degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, and her Ph.D. in Biophysics from the University of Virginia; she completed post-graduate work in Immunology and Virology at the University of Virginia and the University of Tennessee. She is currently a Director at Exelixis, Inc. (NASDAQ: EXEL) and has previously served on the Science Board of the Food and Drug Administration (“FDA”) and as a member of the Commission on a Global Health Risk Framework for the Future of the Institute of Medicine, among others. Her awards include the Department of Health and Human Services Secretary’s Award for Distinguished Service,

What is Maria C. Freire's net worth?

The estimated net worth of Maria C. Freire is at least $9.93 million as of August 14th, 2024. Dr. Freire owns 91,007 shares of Alexandria Real Estate Equities stock worth more than $9,929,774 as of December 3rd. This net worth evaluation does not reflect any other investments that Dr. Freire may own. Learn More about Maria C. Freire's net worth.

How do I contact Maria C. Freire?

The corporate mailing address for Dr. Freire and other Alexandria Real Estate Equities executives is 26 North Euclid Avenue, PASADENA CA, 91101. Alexandria Real Estate Equities can also be reached via phone at (626) 578-0777 and via email at [email protected]. Learn More on Maria C. Freire's contact information.

Has Maria C. Freire been buying or selling shares of Alexandria Real Estate Equities?

Maria C. Freire has not been actively trading shares of Alexandria Real Estate Equities during the last quarter. Most recently, Maria C. Freire sold 2,311 shares of the business's stock in a transaction on Thursday, July 28th. The shares were sold at an average price of $163.04, for a transaction totalling $376,785.44. Following the completion of the sale, the director now directly owns 3,000 shares of the company's stock, valued at $489,120. Learn More on Maria C. Freire's trading history.

Who are Alexandria Real Estate Equities' active insiders?

Alexandria Real Estate Equities' insider roster includes Madeleine Alsbrook (EVP), Marc Binda (EVP), James Cain (Director), Vincent Ciruzzi (Insider), Jackie Clem (General Counsel), John Cunningham (Director), Gary Dean (EVP), Lawrence Diamond (COO), Maria Freire (Director), Kristina Fukuzaki-Carlson (EVP), Andres Gavinet (CAO), Joseph Hakman (COO), Hunter Kass (Director), Joel Marcus (Chairman), Peter Moglia (CEO), Terezia Nemeth (Director), James Richardson (Director), Stephen Richardson (CEO), Daniel Ryan (CIO), and Dean Shigenaga (CFO). Learn More on Alexandria Real Estate Equities' active insiders.

Are insiders buying or selling shares of Alexandria Real Estate Equities?

In the last year, insiders at the real estate investment trust sold shares 6 times. They sold a total of 178,054 shares worth more than $3,970,250.70. The most recent insider tranaction occured on June, 4th when Major Shareholder Real Estate Equitie Alexandria sold 150,000 shares worth more than $631,500.00. Insiders at Alexandria Real Estate Equities own 1.2% of the company. Learn More about insider trades at Alexandria Real Estate Equities.

Information on this page was last updated on 6/4/2024.

Maria C. Freire Insider Trading History at Alexandria Real Estate Equities

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/28/2022Sell2,311$163.04$376,785.443,000View SEC Filing Icon  
2/14/2020Sell1,465$174.20$255,203.003,652View SEC Filing Icon  
8/16/2018Sell3,000$128.67$386,010.003,344View SEC Filing Icon  
5/4/2017Sell2,174$113.30$246,314.205,464View SEC Filing Icon  
See Full Table

Maria C. Freire Buying and Selling Activity at Alexandria Real Estate Equities

This chart shows Maria C Freire's buying and selling at Alexandria Real Estate Equities by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alexandria Real Estate Equities Company Overview

Alexandria Real Estate Equities logo
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Read More

Today's Range

Now: $109.11
Low: $108.34
High: $109.65

50 Day Range

MA: $114.10
Low: $104.31
High: $124.41

2 Week Range

Now: $109.11
Low: $102.89
High: $135.45

Volume

293,936 shs

Average Volume

1,000,676 shs

Market Capitalization

$19.07 billion

P/E Ratio

66.53

Dividend Yield

4.72%

Beta

1.15